Terms: = Colorectal cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Clinical Outcome
21 results:
1. Complete remission in a pretreated, microsatellite-stable,
He L; Li H; Wang Y; Li W; Gao L; Xu B; Hu J; He P; Pu W; Sun G; Wang Z; Han Q; Liu B; Chen H
Front Immunol; 2024; 15():1354613. PubMed ID: 38617840
[TBL] [Abstract] [Full Text] [Related]
2. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
[TBL] [Abstract] [Full Text] [Related]
3. Immune Marker Spatial Distribution and clinical outcome after pd-1 Blockade in Mismatch Repair-deficient, Advanced colorectal Carcinomas.
Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
[TBL] [Abstract] [Full Text] [Related]
4. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
Li Y; Shen Z; Chai Z; Zhan Y; Zhang Y; Liu Z; Liu Y; Li Z; Lin M; Zhang Z; Liu W; Guan S; Zhang J; Qian J; Ding Y; Li G; Fang Y; Deng H
Gut; 2023 Nov; 72(12):2307-2320. PubMed ID: 37507218
[TBL] [Abstract] [Full Text] [Related]
5. Spatially resolved multimarker evaluation of CD274 (PD-L1)/pdcd1 (pd-1) immune checkpoint expression and macrophage polarisation in colorectal cancer.
Elomaa H; Ahtiainen M; Väyrynen SA; Ogino S; Nowak JA; Lau MC; Helminen O; Wirta EV; Seppälä TT; Böhm J; Mecklin JP; Kuopio T; Väyrynen JP
Br J Cancer; 2023 Jun; 128(11):2104-2115. PubMed ID: 37002343
[TBL] [Abstract] [Full Text] [Related]
6. Combined pd-1, BRAF and MEK inhibition in BRAF
Tian J; Chen JH; Chao SX; Pelka K; Giannakis M; Hess J; Burke K; Jorgji V; Sindurakar P; Braverman J; Mehta A; Oka T; Huang M; Lieb D; Spurrell M; Allen JN; Abrams TA; Clark JW; Enzinger AC; Enzinger PC; Klempner SJ; McCleary NJ; Meyerhardt JA; Ryan DP; Yurgelun MB; Kanter K; Van Seventer EE; Baiev I; Chi G; Jarnagin J; Bradford WB; Wong E; Michel AG; Fetter IJ; Siravegna G; Gemma AJ; Sharpe A; Demehri S; Leary R; Campbell CD; Yilmaz O; Getz GA; Parikh AR; Hacohen N; Corcoran RB
Nat Med; 2023 Feb; 29(2):458-466. PubMed ID: 36702949
[TBL] [Abstract] [Full Text] [Related]
7. A novel prognostic immunoscore based on The cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract] [Full Text] [Related]
8. Impact of PD-L1 and pd-1 Expression on the Prognostic Significance of CD8
Munari E; Marconi M; Querzoli G; Lunardi G; Bertoglio P; Ciompi F; Tosadori A; Eccher A; Tumino N; Quatrini L; Vacca P; Rossi G; Cavazza A; Martignoni G; Brunelli M; Netto GJ; Moretta L; Zamboni G; Bogina G
Front Immunol; 2021; 12():680973. PubMed ID: 34122444
[TBL] [Abstract] [Full Text] [Related]
9. Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon cancer: Validation Research Based on Immunohistochemistry Analysis.
Xu J; Yang X; Mao Y; Mei J; Wang H; Ding J; Hua D
Technol Cancer Res Treat; 2021; 20():15330338211019442. PubMed ID: 34060360
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma.
Wang X; Cao K; Guo E; Mao X; Guo L; Zhang C; Guo J; Wang G; Yang X; Sun J; Miao S
Front Immunol; 2021; 12():658631. PubMed ID: 33995377
[TBL] [Abstract] [Full Text] [Related]
11. Microsatellite instability status differentially associates with intratumoral immune microenvironment in human cancers.
Zhang P; Liu M; Cui Y; Zheng P; Liu Y
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32823273
[TBL] [Abstract] [Full Text] [Related]
12. The Latest Findings of pd-1/PD-L1 Inhibitor Application in Gynecologic cancers.
Kooshkaki O; Derakhshani A; Safarpour H; Najafi S; Vahedi P; Brunetti O; Torabi M; Lotfinejad P; Paradiso AV; Racanelli V; Silvestris N; Baradaran B
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708748
[TBL] [Abstract] [Full Text] [Related]
13. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
Kitsou M; Ayiomamitis GD; Zaravinos A
Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
[TBL] [Abstract] [Full Text] [Related]
14. Toxicity associated with pd-1 blockade after allogeneic haematopoietic cell transplantation.
Ortega Sanchez G; Stenner F; Dirnhofer S; Passweg J; Gerull S; Halter JP; Zippelius A; Läubli H
Swiss Med Wkly; 2019 Nov; 149():w20150. PubMed ID: 31707719
[TBL] [Abstract] [Full Text] [Related]
15. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of pd-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract] [Full Text] [Related]
16. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract] [Full Text] [Related]
17. Results and challenges of immune checkpoint inhibitors in colorectal cancer.
Emambux S; Tachon G; Junca A; Tougeron D
Expert Opin Biol Ther; 2018 May; 18(5):561-573. PubMed ID: 29471676
[TBL] [Abstract] [Full Text] [Related]
18. Cytosolic high-mobility group box protein 1 (HMGB1) and/or pd-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy.
Huang CY; Chiang SF; Ke TW; Chen TW; Lan YC; You YS; Shiau AC; Chen WT; Chao KSC
Cancer Immunol Immunother; 2018 Apr; 67(4):551-562. PubMed ID: 29270668
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Steinhäuser K; Kreis NN; Friemel A; Martin D; Wieland U; Rave-Fränk M; Balermpas P; Fokas E; Louwen F; Rödel C; Yuan J
Radiother Oncol; 2018 Feb; 126(2):214-221. PubMed ID: 29122359
[TBL] [Abstract] [Full Text] [Related]
20. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract] [Full Text] [Related]
[Next]
